Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CERE | SMMT | MDGL | ||
| Company | Cerevel Therapeutics Hldg Inc | Summit Therapeu ADR | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 44.99 | 18.02 | 294.00 | ||
| High | 44.99 | 18.60 | 312.52 | ||
| Low | 44.96 | 17.71 | 293.00 | ||
| Last | 44.96 | 17.87 | 308.44 | ||
| Change | +0.33 | -0.53 | +15.03 | ||
| % Change | +0.74% | -2.88% | +5.12% | ||
| Volume | 15,096,300 | 7,099,100 | 716,800 | ||
| 20-Day Average Volume | 2,839,210 | 2,225,100 | 355,750 | ||
| Previous Close | 44.63 | 18.40 | 293.41 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.53 | 18.32 | 316.89 | ||
| 20-Day Raw Stochastic | 99.49% | 44.70% | 30.06% | ||
| 20-Day Relative Strength | 68.05% | 46.59% | 52.97% | ||
| Weighted Alpha | +49.03 | +36.82 | -0.30 | ||
| Today's Opinion | 72% Buy | 24% Buy | 80% Buy | ||
| Previous Opinion | 72% Buy | 56% Buy | 80% Buy | ||
| Last Month's Opinion | 8% Buy | 40% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.67% since 07/24/24 | +0.22% since 12/13/24 | +1.29% since 12/13/24 | ||
| Low | 43.75 on 07/25/24 | 16.83 on 12/18/24 | 289.80 on 12/18/24 | ||
| High | 44.99 on 07/31/24 | 19.18 on 12/17/24 | 315.09 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | +9.95% since 06/28/24 | -4.03% since 11/20/24 | -2.73% since 11/20/24 | ||
| Low | 39.16 on 07/03/24 | 16.52 on 12/03/24 | 289.80 on 12/18/24 | ||
| High | 44.99 on 07/31/24 | 19.54 on 11/26/24 | 351.80 on 11/25/24 | ||
| 3-Month | |||||
| %Chg | +5.27% since 04/30/24 | -26.73% since 09/20/24 | +32.10% since 09/20/24 | ||
| Low | 38.50 on 06/25/24 | 16.52 on 12/03/24 | 200.63 on 10/23/24 | ||
| High | 44.99 on 07/31/24 | 25.50 on 09/23/24 | 368.29 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +6.82% since 01/30/24 | +129.10% since 06/20/24 | +15.18% since 06/20/24 | ||
| Low | 38.50 on 06/25/24 | 6.78 on 07/03/24 | 200.63 on 10/23/24 | ||
| High | 44.99 on 07/31/24 | 33.89 on 09/16/24 | 368.29 on 11/07/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,191,488 | 13,178,196 | 6,727,073 | ||
| Shares Outstanding, K | 182,195 | 737,448 | 21,810 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -432,840,000 | -614,930,000 | -373,630,000 | ||
| Last Quarter Sales | 0 | 0 | 62,180,000 | ||
| Last Quarter Net Income | -131,910,000 | -56,250,000 | -106,960,000 | ||
| 60-Month Beta | 1.40 | -0.92 | -0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/24 | -0.08 on 10/30/24 | -4.92 on 10/31/24 | ||
| Latest Earnings Date | 08/07/24 | 10/30/24 | 10/31/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||